Section 69.41.032 - Prescription of legend drugs and dialysate by dialysis programs(1) This chapter shall not prevent a medicare-approved dialysis center, a facility operating a medicare-approved home dialysis program, a manufacturer, or a wholesaler, from selling, delivering, possessing, or dispensing directly to dialysis patients, if prescribed by a practitioner acting within the scope of the practitioner's practice, those legend drugs, including commercially available dialysate, used by home dialysis patients, in case or full shelf lots, as determined by the commission.(2) The commission shall adopt rules to implement this section.Amended by 2022 c 23,§ 2, eff. 6/9/2022.Amended by 2016 c 148,§ 12, eff. 6/9/2016.Application of pharmacy statutes to dialysis programs: RCW 18.64.257.